ESR1 and breast cancer: In addition, our previous study demonstrated that CDK11p58 inhibited ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling [15] and also we found breast cancers transfected with CDK11p58 grew slowly compared with the control cell lines, so we speculated that CDK11p58 might inhibit the growth of breast cancer.